Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.


Male C., Lensing A., Palumbo J., Kumar R., Nurmeev I., Hege K., ...Daha Fazla

The Lancet. Haematology, cilt.7, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier